LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Oncology Focus MimiVax specializes in developing immunotherapeutic vaccines for cancer treatment, notably SurVaxM for glioblastoma, positioning it as a promising partner for collaborations in cutting-edge cancer immunotherapy.

Regulatory Milestone Receiving FDA Fast Track Designation for SurVaxM indicates accelerated development potential and increased market opportunity, making the company an attractive partner for commercialization initiatives.

Strategic Partnerships Collaboration with Fosun Pharma to develop and commercialize SurVaxM in China opens avenues for expanding into emerging markets and accessing broader patient populations.

Recent Funding & Growth With $10M in debt financing and a revenue range of $1M to $10M, MimiVax is positioned for growth and further clinical development, presenting opportunities for investors and service providers to support its expansion.

Clinical Stage Opportunities Advancing multiple clinical trials across different cancer types suggests multiple product opportunities and risk diversification, ideal for partners offering clinical trial services, diagnostics, or complementary therapeutics.

MimiVax, Inc. Tech Stack

MimiVax, Inc. uses 8 technology products and services including WordPress, Open Graph, Flickity, and more. Explore MimiVax, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • Flickity
    Javascript Libraries
  • imagesLoaded
    Javascript Libraries
  • Lua
    Programming Languages
  • X-XSS-Protection
    Security
  • YouTube
    Video Players
  • OceanWP
    Web Platform Extensions

MimiVax, Inc.'s Email Address Formats

MimiVax, Inc. uses at least 1 format(s):
MimiVax, Inc. Email FormatsExamplePercentage
First.Last@mimivax.comJohn.Doe@mimivax.com
25%
FLast@mimivax.comJDoe@mimivax.com
25%
First.Last@mimivax.comJohn.Doe@mimivax.com
25%
FLast@mimivax.comJDoe@mimivax.com
25%

Frequently Asked Questions

Where is MimiVax, Inc.'s headquarters located?

Minus sign iconPlus sign iconMimiVax, Inc.'s main headquarters is located at Buffalo, New York 14263 United States. The company has employees across 1 continents, including North America.

What is MimiVax, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact MimiVax, Inc.'s main corporate office by phone at
+1-716-845-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MimiVax, Inc.'s official website and social media links?

Minus sign iconPlus sign iconMimiVax, Inc.'s official website is mimivax.com and has social profiles on LinkedIn.

What is MimiVax, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconMimiVax, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MimiVax, Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, MimiVax, Inc. has approximately 3 employees across 1 continents, including North America. Key team members include Vice President Of Clinical Operations: D. D. C.President & Ceo: M. C.Board Member And General Counsel: S. F.. Explore MimiVax, Inc.'s employee directory with LeadIQ.

What industry does MimiVax, Inc. belong to?

Minus sign iconPlus sign iconMimiVax, Inc. operates in the Biotechnology Research industry.

What technology does MimiVax, Inc. use?

Minus sign iconPlus sign iconMimiVax, Inc.'s tech stack includes WordPressOpen GraphFlickityimagesLoadedLuaX-XSS-ProtectionYouTubeOceanWP.

What is MimiVax, Inc.'s email format?

Minus sign iconPlus sign iconMimiVax, Inc.'s email format typically follows the pattern of First.Last@mimivax.com. Find more MimiVax, Inc. email formats with LeadIQ.

How much funding has MimiVax, Inc. raised to date?

Minus sign iconPlus sign icon As of February 2026, MimiVax, Inc. has raised $10M in funding. .

When was MimiVax, Inc. founded?

Minus sign iconPlus sign iconMimiVax, Inc. was founded in 2012.

MimiVax, Inc.

Biotechnology ResearchNew York, United States2-10 Employees

Our vision, to disrupt cancer with the development of highly innovative immunotherapies aimed at increasing patient survival rates

MimiVax is a privately held, clinical-stage biotechnology company focused on the development and commercialization of immunotherapeutic vaccines and targeted therapies for the treatment of cancer. 

SurVaxM, our lead immunotherapeutic vaccine, has completed a Phase 2a clinical trial in adults with newly diagnosed glioblastoma. 

Additional indications are being evaluated through: 
- Phase 1 clinical trials in multiple myeloma combination with REVLIMID® (lenalidomide) 
- Phase 1 in Neuro-Endocrine Tumors (NET)
- Pilot Study in Pediatric High Grade Glioma, recurrent/relapsed Medulloblastoma and DIPG

Section iconCompany Overview

Headquarters
Buffalo, New York 14263 United States
Phone number
+1-716-845-****
Website
mimivax.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    MimiVax, Inc. has raised a total of $10M of funding over 1 rounds. .

  • $1M$10M

    MimiVax, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $10M

    MimiVax, Inc. has raised a total of $10M of funding over 1 rounds. .

  • $1M$10M

    MimiVax, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    D. D. C.
    Vice President Of Clinical Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. C.
    President & Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. F.
    Board Member And General Counsel
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.